The human microbiome, composed of trillions of microorganisms living in the gut, skin, and other body sites, plays a vital role in regulating immunity. A balanced microbiome strengthens immune responses, protects against pathogens, and reduces the risk of autoimmune and inflammatory diseases. Disruption of microbial balance, known as dysbiosis, is linked to conditions such as allergies, obesity, diabetes, and even cancer. Advances in microbiome research are leading to new probiotics, prebiotics, and microbiota-based therapies that enhance immune health and overall well-being.
In 2025, the global microbiome and immunity market—which includes probiotics, microbiome therapeutics, diagnostics, and dietary supplements—is valued at approximately USD 6.8 billion. Growing consumer interest in gut health, coupled with advances in microbiome-based drug development, is expected to drive the market to USD 12.1 billion by 2030, with a CAGR of 11.5%. North America leads due to strong R&D and commercial adoption, while Asia-Pacific shows the fastest growth fueled by rising demand for functional foods and preventive healthcare solutions.
Share this page on your timeline
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance
Tags
Infection Conferences 2026 USA
Vector-Borne Diseases Conferences
Entomology Conferences
HIV/AIDS Conferences
Infection Conferences 2026
Public Health Conferences
Infectious Disease Conferences
Microbiology Conferences
Infection Control Conferences
Contagious Diseases Conferences
Bacteriology Conferences
Infectious Diseases Conferences Europe
Mycology Conferences